Oppenheimer & Co’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $881K | Sell |
48,395
-6,892
| -12% | -$126K | 0.01% | 914 |
|
|
2025
Q1 | $1.1M | Buy |
55,287
+16,871
| +44% | +$335K | 0.02% | 766 |
|
|
2024
Q4 | $659K | Sell |
38,416
-56,522
| -60% | -$969K | 0.01% | 968 |
|
|
2024
Q3 | $1.9M | Buy |
94,938
+43,836
| +86% | +$876K | 0.03% | 571 |
|
|
2024
Q2 | $571K | Sell |
51,102
-43,108
| -46% | -$482K | 0.01% | 965 |
|
|
2024
Q1 | $622K | Sell |
94,210
-27,726
| -23% | -$183K | 0.01% | 918 |
|
|
2023
Q4 | $551K | Buy |
121,936
+4,801
| +4% | +$21.7K | 0.01% | 940 |
|
|
2023
Q3 | $419K | Sell |
117,135
-2,255
| -2% | -$8.07K | 0.01% | 1009 |
|
|
2023
Q2 | $441K | Sell |
119,390
-6,500
| -5% | -$24K | 0.01% | 1024 |
|
|
2023
Q1 | $417K | Buy |
125,890
+3,065
| +2% | +$10.1K | 0.01% | 1009 |
|
|
2022
Q4 | $477K | Sell |
122,825
-77,500
| -39% | -$301K | 0.01% | 923 |
|
|
2022
Q3 | $487K | Buy |
200,325
+30,903
| +18% | +$75.1K | 0.01% | 907 |
|
|
2022
Q2 | $335K | Buy |
+169,422
| New | +$335K | 0.01% | 1064 |
|
|
2020
Q2 | – | Sell |
-10,836
| Closed | -$31K | – | 1254 |
|
|
2020
Q1 | $31K | Buy |
10,836
+810
| +8% | +$2.32K | ﹤0.01% | 1167 |
|
|
2019
Q4 | $40K | Buy |
+10,026
| New | +$40K | ﹤0.01% | 1258 |
|